Overview of clinical studies and liposomal formulations of hamycin
Affiliations
- PMID: 19957536
Item in Clipboard
Overview of clinical studies and liposomal formulations of hamycin
Hindustan Antibiot Bull.
2007.
Abstract
Hamycin, an antifungal agent, has been widely used for tropical applications in fungal infections of human. The present article briefly summarises its clinical studies, progress in the development of liposomal formulations and future research strategy in which both the clinicians and the scientists should be interested.
Similar articles
-
Mannosylated liposomes as carriers for hamycin in the treatment of experimental aspergillosis in Balb/C mice.J Drug Target. 1993;1(2):147-55. doi: 10.3109/10611869308996071. J Drug Target. 1993. PMID: 8069553
-
Is there a role for polyenes in treating invasive mycoses?Curr Opin Infect Dis. 2006 Dec;19(6):565-70. doi: 10.1097/QCO.0b013e328010851d. Curr Opin Infect Dis. 2006. PMID: 17075332 Review.
-
Liposomal hamycin in the control of experimental aspergillosis in mice: relative toxicity, therapeutic efficacy and tissue distribution of free and liposomal hamycin.Indian J Biochem Biophys. 1992 Aug;29(4):339-45. Indian J Biochem Biophys. 1992. PMID: 1427960
-
Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.Curr Opin Investig Drugs. 2004 Aug;5(8):873-8. Curr Opin Investig Drugs. 2004. PMID: 15600244 Review.
-
Liposomal amphotericin B for the treatment of severe fungal infection.Dynamics. 2001 Spring;12(1):17-21. Dynamics. 2001. PMID: 11982230 Review.
MeSH terms
Substances
LinkOut - more resources
Medical